← Leaderboards
Pouneh Khadejeh Fazeli
Massachusetts General Hospital
$3,583,785
Attributed
$4,594,637
Total exposure
4
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1M · FY2012–25$2M$1.5M$1M$500K$0
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$4,594,637 · 4
By mechanism
R01$3,682,033 · 2
K23$746,348 · 1
R03$166,256 · 1
Top collaborators
- Matthew Steinhauser3 shared
Most similar at Massachusetts General Hospital
Same institution · by research overlap
- Madhusmita Misra$12,646,884
- Benjamin Z Leder$7,400,681
- Marc Nathan Wein$4,989,017
- Joel S Finkelstein$18,947,740
- Miriam Antoinette Bredella$11,700,851
Others in their field
Top investigators on “Bone”
- David Heimbrook · Leidos Biomedical Research, Inc.$240,577,094
- Charles A Coltman · Southwest Oncology Group$141,983,231
- Mary M Horowitz · Medical College Of Wisconsin$136,789,389
- Gregory D Peterson · University Of Tennessee Knoxville$84,527,696
- Richard A Gibbs · Baylor College Of Medicine$64,141,825
- Jeffrey Krischer · University Of South Florida$61,545,982
Research focus
BoneBone DensityResolutionBone LossPeripheralBody Weight DecreasedResponseRandomizedInvestigationAffectBone TurnoverAreaComplicationComorbidityOsteoporosisBone ResorptionFractureMorbidity - Disease RateBone StrengthEstrogensFatty Acid Glycerol EstersBone MassAnorexia NervosaAdipose Tissue
Grant awards (14)
Beneficial reprogramming of lipid metabolism with intermittent fasting$666,071
R01 · FY2025 · DK · contact PI
Beneficial reprogramming of lipid metabolism with intermittent fasting$663,984
R01 · FY2024 · DK · contact PI
Beneficial reprogramming of lipid metabolism with intermittent fasting$691,650
R01 · FY2023 · DK · contact PI
Transdermal estrogen for the treatment of bone loss in women with anorexia nervosa$336,431
R01 · FY2023 · HD · contact PI
Transdermal estrogen for the treatment of bone loss in women with anorexia nervosa$337,513
R01 · FY2022 · HD · contact PI
Transdermal estrogen for the treatment of bone loss in women with anorexia nervosa$323,654
R01 · FY2021 · HD · contact PI
Transdermal estrogen for the treatment of bone loss in women with anorexia nervosa$330,260
R01 · FY2020 · HD · contact PI
Transdermal estrogen for the treatment of bone loss in women with anorexia nervosa$332,470
R01 · FY2019 · HD · contact PI
Transdermal Estrogen in Older Premenopausal Women with Anorexia Nervosa$83,128
R03 · FY2016 · DK · contact PI
The Role of PTH in the Low Bone Mass of Anorexia Nervosa$186,587
K23 · FY2015 · DK · contact PI
Transdermal Estrogen in Older Premenopausal Women with Anorexia Nervosa$83,128
R03 · FY2015 · DK · contact PI
The Role of PTH in the Low Bone Mass of Anorexia Nervosa$186,587
K23 · FY2014 · DK · contact PI
The Role of PTH in the Low Bone Mass of Anorexia Nervosa$186,587
K23 · FY2013 · DK · contact PI
The Role of PTH in the Low Bone Mass of Anorexia Nervosa$186,587
K23 · FY2012 · DK · contact PI